SELLAS Life Sciences Group, Inc.
SLS
$1.43
$0.042.52%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -4.50% | 5.04% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 3.06% | 13.36% | |||
| Operating Income | -3.06% | -13.36% | |||
| Income Before Tax | -2.88% | -13.56% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.88% | -13.56% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.88% | -13.56% | |||
| EBIT | -3.06% | -13.36% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 6.57% | -1.21% | |||
| Normalized Basic EPS | 6.44% | -1.21% | |||
| EPS Diluted | 10.57% | -5.74% | |||
| Normalized Diluted EPS | 6.44% | -1.21% | |||
| Average Basic Shares Outstanding | 9.98% | 12.30% | |||
| Average Diluted Shares Outstanding | 9.98% | 12.30% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||